Transcat Future Growth

Future criteria checks 2/6

Transcat se prevé un crecimiento anual de los beneficios y los ingresos de 21.1% y 8.4% respectivamente. Se prevé que el BPA sea de grow en 17.5% al año. Se prevé que la rentabilidad de los fondos propios sea de 10.8% en 3 años.

Key information

14.8%

Earnings growth rate

12.6%

EPS growth rate

Trade Distributors earnings growth	7.7%
Revenue growth rate	5.5%
Future return on equity	10.6%
Analyst coverage	Low
Last updated	08 Feb 2024

Recent future growth updates

Recent updates

Transcat Scores Wins On The Top And Bottom Lines, But Is Still Too Expensive

Feb 01

There Are Reasons To Feel Uneasy About Transcat's (NASDAQ:TRNS) Returns On Capital

Dec 19

Transcat acquires Complete Calibrations for $1.2M and e2b Calibration for $3.15M

Sep 28

We Think Transcat (NASDAQ:TRNS) Can Stay On Top Of Its Debt

Aug 05

Transcat (NASDAQ:TRNS) Has Some Way To Go To Become A Multi-Bagger

Jul 24

What Is Transcat, Inc.'s (NASDAQ:TRNS) Share Price Doing?

Jul 13

Is Transcat, Inc. (NASDAQ:TRNS) Trading At A 38% Discount?

Jun 17

Returns At Transcat (NASDAQ:TRNS) Appear To Be Weighed Down

Apr 02

Should You Be Adding Transcat (NASDAQ:TRNS) To Your Watchlist Today?

Feb 02

I Ran A Stock Scan For Earnings Growth And Transcat (NASDAQ:TRNS) Passed With Ease

Nov 03

Shareholders Would Not Be Objecting To Transcat, Inc.'s (NASDAQ:TRNS) CEO Compensation And Here's Why

Sep 01

These 4 Measures Indicate That Transcat (NASDAQ:TRNS) Is Using Debt Reasonably Well

Jul 13

Returns On Capital At Transcat (NASDAQ:TRNS) Have Stalled

Jun 09

Earnings and Revenue Growth Forecasts

NasdaqGM:TRNS - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
3/31/2027	304	18	N/A	28	1
3/31/2026	289	17	12	28	1
3/31/2025	280	19	18	33	5
3/31/2024	257	12	10	31	5
12/23/2023	251	10	19	30	N/A
9/23/2023	243	9	18	28	N/A
6/24/2023	237	11	13	22	N/A
3/25/2023	231	11	8	17	N/A
12/24/2022	224	10	8	19	N/A
9/24/2022	218	10	4	15	N/A
6/25/2022	212	11	6	18	N/A
3/26/2022	205	11	7	18	N/A
12/25/2021	198	12	12	20	N/A
9/25/2021	191	12	11	19	N/A
6/26/2021	182	11	15	22	N/A
3/27/2021	173	8	17	24	N/A
12/26/2020	170	7	13	19	N/A
9/26/2020	169	7	16	21	N/A
6/27/2020	170	7	8	15	N/A
3/28/2020	173	8	5	12	N/A
12/28/2019	172	8	7	14	N/A
9/28/2019	170	8	3	11	N/A
6/29/2019	167	7	4	10	N/A
3/30/2019	161	7	6	13	N/A
12/29/2018	159	7	5	11	N/A
9/29/2018	158	7	7	13	N/A
6/30/2018	156	6	10	16	N/A
3/31/2018	155	6	4	10	N/A
12/23/2017	151	5	3	9	N/A
9/23/2017	148	4	N/A	4	N/A
6/24/2017	147	4	N/A	5	N/A
3/25/2017	144	5	N/A	8	N/A
12/24/2016	138	5	N/A	7	N/A
9/24/2016	131	4	N/A	11	N/A
6/25/2016	126	4	N/A	8	N/A
3/26/2016	122	4	N/A	11	N/A
12/26/2015	122	4	N/A	11	N/A
9/26/2015	123	4	N/A	10	N/A
6/27/2015	124	4	N/A	9	N/A
3/28/2015	124	4	N/A	4	N/A
12/27/2014	122	4	N/A	5	N/A
9/27/2014	121	4	N/A	7	N/A
6/28/2014	119	4	N/A	6	N/A
3/29/2014	119	4	N/A	8	N/A
12/28/2013	119	4	N/A	7	N/A
9/28/2013	118	4	N/A	5	N/A
6/29/2013	116	4	N/A	7	N/A

Analyst Future Growth Forecasts

Ingresos vs. tasa de ahorro: TRNS(21.1% al año) es superior a la tasa de ahorro (2.2%).

Beneficios frente mercado: TRNSSe prevé que los beneficios de la empresa (21.1% al año) crezcan más deprisa que el mercado US (14.9% al año).

Beneficios de alto crecimiento: TRNSSe prevé que los beneficios de la empresa crezcan, pero no significativamente.

Ingresos vs. Mercado: TRNS(5.8% al año) se prevé que crezca más despacio que el mercado de US (8.1% al año).

Ingresos de alto crecimiento: TRNSSe prevé que los ingresos de la empresa (8.4% al año) crezcan más despacio que 20% al año.

Earnings per Share Growth Forecasts

Future Return on Equity

Futura rentabilidad financiera (ROE): TRNSSe prevé que la Rentabilidad de los fondos propios de la empresa sea baja dentro de 3 años (10.8%).

Discover growth companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Transcat Future Growth

Future criteria checks 2/6

Key information

Recent future growth updates

Price target increased by 10% to US$119

Transcat, Inc. Provides Earnings Guidance for the Fiscal Year 2024

Consensus EPS estimates fall by 21%

Transcat, Inc. Provides Financial Guidance for the Fiscal Year 2024

Consensus EPS estimates increase by 10%

Price target increased by 9.5% to US$92.60

Recent updates

President recently sold US$1.1m worth of stock

President notifies of intention to sell stock

Price target increased by 10% to US$119

Transcat Scores Wins On The Top And Bottom Lines, But Is Still Too Expensive

Transcat, Inc. Announces Board Changes

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Transcat, Inc. Provides Earnings Guidance for the Fiscal Year 2024

Transcat, Inc. to Report Q3, 2024 Results on Jan 29, 2024

There Are Reasons To Feel Uneasy About Transcat's (NASDAQ:TRNS) Returns On Capital

President notifies of intention to sell stock

Independent Director recently bought US$100k worth of stock

Transcat's (NASDAQ:TRNS) Problems Go Beyond Weak Profit

Consensus EPS estimates fall by 21%

New minor risk - Earnings quality

High number of new directors

Transcat, Inc. Appoints Dawn DePerrior to the Board

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Transcat, Inc. Provides Financial Guidance for the Fiscal Year 2024

Transcat, Inc. to Report Q2, 2024 Results on Oct 30, 2023

Chief Operating Officer exercised options and sold US$144k worth of stock

Transcat, Inc. has completed a Follow-on Equity Offering in the amount of $70.000275 million.

Transcat, Inc. has completed a Follow-on Equity Offering in the amount of $70.000275 million.

Investor sentiment deteriorates as stock falls 16%

New minor risk - Shareholder dilution

President recently sold US$264k worth of stock

President notifies of intention to sell stock

Consensus EPS estimates increase by 10%

Transcat, Inc. (NasdaqGM:TRNS) acquired Axiom Test Equipment, Inc. for $38 million.

Capital Allocation Trends At Transcat (NASDAQ:TRNS) Aren't Ideal

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Transcat, Inc., Annual General Meeting, Sep 06, 2023

Transcat, Inc. to Report Q1, 2024 Results on Jul 31, 2023

Independent Director recently sold US$301k worth of stock

Full year 2023 earnings released: EPS: US$1.42 (vs US$1.52 in FY 2022)

Transcat, Inc. to Report Q4, 2023 Results on May 22, 2023

Transcat (NASDAQ:TRNS) Hasn't Managed To Accelerate Its Returns

Insider recently sold US$90k worth of stock

Independent Director recently sold US$436k worth of stock

Price target increased by 9.5% to US$92.60

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Transcat, Inc. to Report Q3, 2023 Results on Jan 30, 2023

Consensus forecasts updated

Independent Director recently sold US$181k worth of stock

Price target increased to US$86.60

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Are Transcat, Inc. (NASDAQ:TRNS) Investors Paying Above The Intrinsic Value?

Transcat, Inc. to Report Q2, 2023 Results on Oct 31, 2022

Investor sentiment improved over the past week

Transcat, Inc. (NasdaqGM:TRNS) acquired Galium Limited for $1.2 million.

Transcat acquires Complete Calibrations for $1.2M and e2b Calibration for $3.15M

Transcat, Inc. Elects Cynthia Langston as Directors

Consensus EPS estimates increase by 11%

We Think Transcat (NASDAQ:TRNS) Can Stay On Top Of Its Debt

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Transcat, Inc. Appoints Tom Barbato as Chief Financial Officer

Transcat, Inc. Announces Resignation of Carl E. Sassano from Board, Effective July 26, 2022

Transcat (NASDAQ:TRNS) Has Some Way To Go To Become A Multi-Bagger

Transcat, Inc., Annual General Meeting, Sep 07, 2022

Transcat, Inc. to Report Q1, 2023 Results on Aug 01, 2022

What Is Transcat, Inc.'s (NASDAQ:TRNS) Share Price Doing?

Price target decreased to US$80.50

Price target decreased to US$82.50

Is Transcat, Inc. (NASDAQ:TRNS) Trading At A 38% Discount?

Transcat, Inc. (NasdaqGM:TRNS) acquired Substantially All Assets of Alliance Calibration, LLC for $4.7 million.

Independent Director recently sold US$1.3m worth of stock

Consensus forecasts updated

Independent Director notifies of intention to sell stock

Full year 2022 earnings: EPS misses analyst expectations

Transcat, Inc. to Report Q4, 2022 Results on May 23, 2022